Vcanbio Cell & Gene Engineering Corp

Vcanbio Cell & Gene Engineering Corp Rule of 40

The Rule of 40 of Vcanbio Cell & Gene Engineering Corp (600645.SS) as of Oct 16, 2026 is 5.28 %. In the previous year, Rule of 40 was 8.29 % — a change of -36.35% (lower).

Rule of 40

5.28 %

YoY

-36.35%

Last updated:

Rule of 40 of Vcanbio Cell & Gene Engineering Corp is 2025 5.28 % . Rule of 40 of Vcanbio Cell & Gene Engineering Corp was 2024 8.29 % . It decreases by -36.35% lower compared to the previous year.

The Vcanbio Cell & Gene Engineering Corp Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2018
3.32 CNY
Jan 1, 2019
13.30 CNY
Jan 1, 2020
-11.92 CNY
Jan 1, 2021
30.73 CNY
Jan 1, 2022
11.31 CNY
Jan 1, 2023
10.49 CNY
Jan 1, 2024
8.29 CNY
Jan 1, 2025
5.28 CNY
The Vcanbio Cell & Gene Engineering Corp Rule of 40 history
YEARRule of 40YoY
5.28 %-36.35%
8.29 %-20.92%
10.49 %-7.24%
11.31 %-63.20%
30.73 %-357.71%
-11.92 %-189.66%
13.30 %+300.63%
3.32 %-94.68%
62.39 %+121.13%
28.21 %-66.52%
84.28 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Vcanbio Cell & Gene Engineering Corp Stock analysis

What does Vcanbio Cell & Gene Engineering Corp do? Vcanbio Cell & Gene Engineering Corp Ltd is a biotechnology company based in Tianjin, China, operating within the healthcare sector. The company has been publicly traded since its IPO on May 4, 1993, and is listed under the ticker 600645.SS with ISIN CNE000000545. It employs 2,332 full-time staff and focuses on the development of life sciences technology. Vcanbio engages in cell culture, gene detection, and storage services, as well as the production and sale of cytokines culture solutions, cosmetics, and detection reagents. The company primarily serves domestic markets in China, with its headquarters located in Tianjin. Its website is http://www.vcanbio.com. The firm's business activities include the development and application of biotechnology solutions, though specific details on product names, acquisitions, or additional financial figures are not provided in the available information. Vcanbio operates as a public company with a presence in the Chinese biotechnology industry, emphasizing innovation in cell and gene engineering. Vcanbio Cell & Gene Engineering Corp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vcanbio Cell & Gene Engineering Corp stock

Rule of 40 of Vcanbio Cell & Gene Engineering Corp is 5.28 % in 2025.

On Eulerpool you can find the complete historical development of Rule of 40 Vcanbio Cell & Gene Engineering Corp since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Quality — Vcanbio Cell & Gene Engineering Corp

AAQSPiotroski F-ScoreAltman Z-ScoreGraham NumberRule of 40

All Key Metrics — Vcanbio Cell & Gene Engineering Corp